Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-25-057808
Filing Date
2025-06-25
Accepted
2025-06-25 16:22:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4857
  Complete submission text file 0001213900-25-057808.txt   6778
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Subject) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-80327 | Film No.: 251073864
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 100 MERRICK ROAD, SUITE 400W ROCKVILLE CENTRE NY 11570
Business Address 100 MERRICK ROAD, SUITE 400W ROCKVILLE CENTRE NY 11570 516-887-6000
Hewlett Fund LP (Filed by) CIK: 0001711607 (see all company filings)

EIN.: 061519205 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SCHEDULE 13G/A